2018
DOI: 10.1016/j.stemcr.2017.11.008
|View full text |Cite
|
Sign up to set email alerts
|

FZD4 Marks Lateral Plate Mesoderm and Signals with NORRIN to Increase Cardiomyocyte Induction from Pluripotent Stem Cell-Derived Cardiac Progenitors

Abstract: SummaryThe identification of cell surface proteins on stem cells or stem cell derivatives is a key strategy for the functional characterization, isolation, and understanding of stem cell population dynamics. Here, using an integrated mass spectrometry- and microarray-based approach, we analyzed the surface proteome and transcriptome of cardiac progenitor cells (CPCs) generated from the stage-specific differentiation of mouse and human pluripotent stem cells. Through bioinformatics analysis, we have identified … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
25
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(26 citation statements)
references
References 45 publications
1
25
0
Order By: Relevance
“…Patterning into cardiac versus presumptive presomitic mesoderm was confirmed by targeted heatmap analysis for associated GO terms, including osteoblast, skeletal muscle, mesenchyme, somite, and limb development. Remarkably, day-3 analysis of IWP-treated cells showed robust upregulation of key cardiac progenitor markers including ISL1 , GATA4 , MEF2C , NXK2-6 (Biben et al., 1998), FZD4 (Yoon et al., 2018), and FOXC1/2 , as well as TTN and TNNI1 (Figure 1E). Conversely, markers described to inhibit cardiac mesoderm but to promote presomitic specification including CDX1/2 and MSX1/2 (Greber et al., 2010, Mendjan et al., 2014) were significantly upregulated in the absence of early IWP2 treatment (confirmed for CDX2 by FC; Figure S1E).…”
Section: Resultsmentioning
confidence: 97%
See 2 more Smart Citations
“…Patterning into cardiac versus presumptive presomitic mesoderm was confirmed by targeted heatmap analysis for associated GO terms, including osteoblast, skeletal muscle, mesenchyme, somite, and limb development. Remarkably, day-3 analysis of IWP-treated cells showed robust upregulation of key cardiac progenitor markers including ISL1 , GATA4 , MEF2C , NXK2-6 (Biben et al., 1998), FZD4 (Yoon et al., 2018), and FOXC1/2 , as well as TTN and TNNI1 (Figure 1E). Conversely, markers described to inhibit cardiac mesoderm but to promote presomitic specification including CDX1/2 and MSX1/2 (Greber et al., 2010, Mendjan et al., 2014) were significantly upregulated in the absence of early IWP2 treatment (confirmed for CDX2 by FC; Figure S1E).…”
Section: Resultsmentioning
confidence: 97%
“…Opposing the gene expression patterns specific to cardiac mesoderm (resulting from immediate IWP addition on day 1) versus presomitic mesoderm (achieved by the lack of IWP before day 3) allowed us to evaluate several known cardiac/mesodermal progenitor markers including KDR, PDGFRα, SSEA1, NCAM, ROR2, and CD13 (Ardehali et al., 2013, Evseenko et al., 2010, Kattman et al., 2011, Lee et al., 2017, Nelson et al., 2008, Yang et al., 2008, Yoon et al., 2018) regarding their suitability for early process monitoring and eventually predicting functional CM formation at later stages. Interestingly, none of the established markers was well suited to discriminate early cardiac from presomitic mesoderm.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Expression of Flk1 and Pdgfra together is generally predictive of CM potential in hPSCs (Kattman et al 2011). Several other markers have recently been proposed for the isolation of hPSC-derived cardiac progenitors, such as Ror2 and Cd13 (Drukker et al 2012;Den Hartogh et al 2015;Skelton et al 2016), or Fzd4 (Yoon et al 2018).…”
Section: Markers Of Early Cpcsmentioning
confidence: 99%
“…While pathways that are active in a given type of cell may be inferred from previous developmental or functional studies (Zhou et al, 2015;Fan et al, 2016;Yoon et al, 2018;van der Kant et al, 2019), such research may not yet have been completed for a given tissue of interest. Even if it has, there is no guarantee that all relevant interactions have been identified.…”
Section: Introductionmentioning
confidence: 99%